12:50 ~ 13:05 |
Management of recurrent low-grade intermediate-risk bladder cancer despite intravesical chemotherapy or BCG |
Se Young CHOI (Korea) |
|
13:05 ~ 13:20 |
Is re-TURB really necessary for all high-grade NMIBC? |
Sungchan PARK (Korea) |
|
13:20 ~ 13:50 |
Emerging therapies in non-muscle invasive bladder cancer |
Seth LERNER (USA) |
|
13:50 ~ 14:00 |
Case Discussion : Low grade, recurrent, intermediate-risk NMIBC refractory to BCG |
Moderator: Taek Sang KIM (Korea) Kyung Jin JUNG (Korea) Kwang Hyun KIM (Korea) Lukman HAKIM (Indonesia) |
|